HK1195773A1 - 抑制劑的鹽類 - Google Patents

抑制劑的鹽類

Info

Publication number
HK1195773A1
HK1195773A1 HK14109258.2A HK14109258A HK1195773A1 HK 1195773 A1 HK1195773 A1 HK 1195773A1 HK 14109258 A HK14109258 A HK 14109258A HK 1195773 A1 HK1195773 A1 HK 1195773A1
Authority
HK
Hong Kong
Prior art keywords
plk
inhibitor salts
salts
inhibitor
plk inhibitor
Prior art date
Application number
HK14109258.2A
Other languages
English (en)
Inventor
．贊姆皮裡
．伯利亞
．艾羅爾迪
．坎迪亞尼
．弗裡吉利奧
Original Assignee
內爾維阿諾醫學科學有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 內爾維阿諾醫學科學有限公司 filed Critical 內爾維阿諾醫學科學有限公司
Publication of HK1195773A1 publication Critical patent/HK1195773A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK14109258.2A 2009-07-29 2014-09-12 抑制劑的鹽類 HK1195773A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09166760 2009-07-29

Publications (1)

Publication Number Publication Date
HK1195773A1 true HK1195773A1 (zh) 2014-11-21

Family

ID=42735665

Family Applications (2)

Application Number Title Priority Date Filing Date
HK12106801.2A HK1166015A1 (zh) 2009-07-29 2012-07-11 抑制劑的鹽類
HK14109258.2A HK1195773A1 (zh) 2009-07-29 2014-09-12 抑制劑的鹽類

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK12106801.2A HK1166015A1 (zh) 2009-07-29 2012-07-11 抑制劑的鹽類

Country Status (9)

Country Link
US (1) US8648078B2 (zh)
EP (1) EP2459196B1 (zh)
JP (1) JP5851990B2 (zh)
CN (2) CN103626777B (zh)
AR (1) AR077422A1 (zh)
ES (1) ES2553114T3 (zh)
HK (2) HK1166015A1 (zh)
TW (1) TW201109334A (zh)
WO (1) WO2011012534A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5400791B2 (ja) * 2007-12-04 2014-01-29 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ 置換ジヒドロプテリジン−６−オン誘導体、その製造方法及びキナーゼ阻害剤としてのその使用
CN102382106A (zh) * 2010-08-30 2012-03-21 黄振华 苯胺取代的喹唑啉衍生物
MX342873B (es) 2010-12-17 2016-10-17 Nerviano Medical Sciences S R L * Derivados de pirazolo-quinazolina sustituidos como inhibidores de cinasa.
WO2012101032A1 (en) * 2011-01-26 2012-08-02 Nerviano Medical Sciences S.R.L. Tricyclic pyrrolo derivatives, process for their preparation and their use as kinase inhibitors
JP5925808B2 (ja) * 2011-01-26 2016-05-25 ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ 三環式誘導体、これらの調製方法およびこれらのキナーゼ阻害剤としての使用
WO2012118802A1 (en) 2011-02-28 2012-09-07 Transgenomic, Inc. Kit and method for sequencing a target dna in a mixed population
USRE48974E1 (en) 2014-04-07 2022-03-15 Netherlands Translational Research Center B.V. (5,6-dihydro)pyrimido[4,5-E]indolizines
US9684547B2 (en) 2014-05-29 2017-06-20 Apple Inc. Method and apparatus for handling security of an application and its extension
US20210222228A1 (en) 2018-08-26 2021-07-22 Cardiff Oncology, Inc. Plk1 target phosphorylation status and treatment of cancer with plk1 inhibitors
WO2023104178A1 (zh) * 2021-12-10 2023-06-15 山东绿叶制药有限公司 蛋白激酶抑制剂及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582831A (en) * 1984-11-16 1986-04-15 Pfizer Inc. Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor
ES2436524T3 (es) * 2003-05-22 2014-01-02 Nerviano Medical Sciences S.R.L. Derivados de pirazolo-quinazolina, procedimiento para su preparación y su uso como inhibidores de cinasas
EA014231B1 (ru) * 2006-02-10 2010-10-29 НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. Комбинации, включающие ингибитор cdk и антитело фактора роста или антимитотик
TW200808311A (en) * 2006-03-30 2008-02-16 Nerviano Medical Sciences Srl Use of a kinase inhibitor for the treatment of particular resistant tumors
EP2125822B1 (en) * 2006-12-21 2014-11-19 Nerviano Medical Sciences S.R.L. Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
AR076784A1 (es) * 2009-05-26 2011-07-06 Nerviano Medical Sciences Srl Combinacion terapeutica que comprende un inhibidor de plk1 y un agente antineoplasico

Also Published As

Publication number Publication date
CN102470136A (zh) 2012-05-23
US20120157468A1 (en) 2012-06-21
WO2011012534A1 (en) 2011-02-03
AR077422A1 (es) 2011-08-24
ES2553114T3 (es) 2015-12-04
CN103626777A (zh) 2014-03-12
US8648078B2 (en) 2014-02-11
CN102470136B (zh) 2013-12-25
HK1166015A1 (zh) 2012-10-19
EP2459196B1 (en) 2015-09-09
EP2459196A1 (en) 2012-06-06
JP2013500299A (ja) 2013-01-07
CN103626777B (zh) 2015-10-21
TW201109334A (en) 2011-03-16
JP5851990B2 (ja) 2016-02-03

Similar Documents

Publication Publication Date Title
HK1179477A1 (zh) 激酶抑制劑
ZA201203842B (en) Kinase inhibitors
HK1195773A1 (zh) 抑制劑的鹽類
ZA201204260B (en) Tracking method
GB0908772D0 (en) New salts 756
EP2558099A4 (en) Kinase Inhibitors
HK1169408A1 (zh) 抑制劑的鹽類
ZA201108131B (en) Dihydroorotate- dehydrogenasee inhibitors as virostatic compounds
EP2519508A4 (en) METALLO ENZYME INHIBITOR COMPOUNDS
IL218967A0 (en) Phenyloxadiazole derivatives as pgds inhibitors
HK1210159A1 (zh) 抑制劑
GB0907886D0 (en) Corrosion inhibitor
GB0901898D0 (en) Dual calpain-ros inhibitors
EP2480076A4 (en) IMIDAZOTHIAZOLIC INHIBITORS OF KINASES
EP2496230A4 (en) INHIBITORS OF IRE-1 ALPHA
GB0807451D0 (en) Inhibitors of PLK
ZA201102837B (en) Phosphodiestarase inhibitors
ZA201009284B (en) Antiviral salts
GB0916010D0 (en) JMJD2 demethylase inhibitors
HK1175780A1 (zh) 晶體 抑制劑鹽
GB0807452D0 (en) PLK inhibitors
ZA201200811B (en) Cathepsin c inhibitors
GB0914726D0 (en) Kinase inhibitors
GB0901900D0 (en) Dual calpain-ros inhibitors
EP2446210A4 (en) EXCHANGER CONFIGURATION